Faraco, Giuseppe
Hochrainer, Karin
Segarra, Steven G.
Schaeffer, Samantha
Santisteban, Monica M.
Menon, Ajay
Jiang, Hong
Holtzman, David M.
Anrather, Josef
Iadecola, Costantino
Article History
Received: 31 May 2018
Accepted: 24 September 2019
First Online: 23 October 2019
Change Date: 14 January 2020
Change Type: Correction
Change Details: An Amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: D.M.H. is listed as an inventor on a patent licensed by Washington University to C2N Diagnostics and subsequently AbbVie on the therapeutic use of anti-tau antibodies; co-founded and is on the scientific advisory board of C2N Diagnostics; and is on the scientific advisory board of Denali, Genentech, and Proclara. C.I. is on the scientific advisory board of Broadview Ventures.